chr2-25161179-G-C
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 1P and 12B. PP3BP4_StrongBS1BS2
The NM_000939.4(POMC):āc.706C>Gā(p.Arg236Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00434 in 1,613,852 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R236Q) has been classified as Likely benign.
Frequency
Consequence
NM_000939.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POMC | NM_000939.4 | c.706C>G | p.Arg236Gly | missense_variant | 3/3 | ENST00000395826.7 | NP_000930.1 | |
POMC | NM_001035256.3 | c.706C>G | p.Arg236Gly | missense_variant | 4/4 | NP_001030333.1 | ||
POMC | NM_001319204.2 | c.706C>G | p.Arg236Gly | missense_variant | 4/4 | NP_001306133.1 | ||
POMC | NM_001319205.2 | c.706C>G | p.Arg236Gly | missense_variant | 3/3 | NP_001306134.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POMC | ENST00000395826.7 | c.706C>G | p.Arg236Gly | missense_variant | 3/3 | 2 | NM_000939.4 | ENSP00000379170 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00284 AC: 433AN: 152214Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.00269 AC: 675AN: 250890Hom.: 3 AF XY: 0.00259 AC XY: 352AN XY: 135696
GnomAD4 exome AF: 0.00449 AC: 6569AN: 1461520Hom.: 28 Cov.: 32 AF XY: 0.00436 AC XY: 3173AN XY: 727076
GnomAD4 genome AF: 0.00284 AC: 433AN: 152332Hom.: 1 Cov.: 33 AF XY: 0.00294 AC XY: 219AN XY: 74494
ClinVar
Submissions by phenotype
not provided Pathogenic:3Uncertain:1Benign:1
Pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Pathogenic, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Pathogenic, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 23, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 16, 2019 | The R236G variant in the POMC gene has been reported previously in the heterozygous state in multiple individuals with obesity (Miraglia del Giudice et al., 2001; Challis et al., 2002; Buono et al., 2005; Lee et al., 2006; Creemers et al., 2008; Dubern et al., 2008; Shabana et al., 2016; Nordang et al., 2017). While it has also been reported in control populations, the frequency appears to be higher in individuals with obesity, and R236G is felt to confer an increased risk for obesity (Shabana et al., 2016). The R236G variant is observed in 234/66,206 (0.35%) alleles from individuals of European (non-Finnish) background in the ExAC dataset (Lek et al., 2016). The R236G variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution disrupts the dibasic cleavage site at a position that is conserved across species (Challis et al., 2002). Functional studies demonstrate that R236G is associated with expression of an abnormal fusion protein that interferes with MC4R signaling (Challis et al., 2002). We interpret R236G as a risk allele. - |
Obesity due to pro-opiomelanocortin deficiency Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Dec 21, 2022 | _x000D_ Criteria applied: PS3_SUP, PS4_SUP, PP1, PP3 - |
Obesity due to pro-opiomelanocortin deficiency;C4054476:Inherited obesity Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Jan 26, 2023 | - - |
POMC-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 31, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Obesity, early-onset, susceptibility to Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Aug 15, 2002 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at